<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0010">
 <label>10</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Pearson</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>García-Echeverría</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fabbro</surname>
    <given-names>D</given-names>
   </name>
  </person-group>, 
  <chapter-title>Protein tyrosine kinases as targets for cancer and other indications</chapter-title> In: 
  <person-group person-group-type="editor">
   <name name-style="western">
    <surname>Fabbro</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mc Cormick</surname>
    <given-names>F</given-names>
   </name>
  </person-group>, eds. 
  <source>Protein tyrosine kinases - from inhibitors to useful drugs</source>. 
  <publisher-loc>Totowa (NJ)</publisher-loc>: 
  <publisher-name>Humana Press Inc</publisher-name>; 
  <year>2006</year>:
  <fpage>1</fpage>–
  <lpage>29</lpage>.
 </mixed-citation>
</ref>
